MM
CVS icon

Meridian Management’s CVS Health CVS Stock Holding History

Meridian Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-61,210
Closed -$4.23M – 96
2023
Q2 		$4.23M Buy
61,210
+7,837
+15% +$558K 1.33% 20
2023
Q1 		$3.97M Sell
53,373
-1,937
-4% -$162K 1.3% 21
2022
Q4 		$5.15M Buy
55,310
+759
+1% +$73.2K 1.88% 12
2022
Q3 		$5.2M Buy
54,551
+1,087
+2% +$108K 2.08% 11
2022
Q2 		$4.95M Sell
53,464
-2,132
-4% -$208K 1.92% 11
2022
Q1 		$5.63M Sell
55,596
-847
-2% -$89K 1.78% 12
2021
Q4 		$5.82M Buy
56,443
+264
+0.5% +$24.4K 1.69% 13
2021
Q3 		$4.77M Buy
56,179
+2,567
+5% +$215K 1.46% 17
2021
Q2 		$4.47M Sell
53,612
-10,176
-16% -$833K 1.32% 19
2021
Q1 		$4.8M Buy
63,788
+1,221
+2% +$88.9K 1.49% 18
2020
Q4 		$4.27M Buy
62,567
+5
+0% +$325 1.37% 22
2020
Q3 		$3.65M Buy
62,562
+12,210
+24% +$760K 1.36% 20
2020
Q2 		$3.27M Sell
50,352
-11
-0% -$693 1.34% 21
2020
Q1 		$2.99M Buy
50,363
+408
+0.8% +$27.2K 1.44% 21
2019
Q4 		$3.71M Buy
49,955
+535
+1% +$37.6K 1.49% 17
2019
Q3 		$3.12M Buy
49,420
+7,550
+18% +$447K 1.39% 23
2019
Q2 		$2.28M Buy
41,870
+550
+1% +$29.6K 1.01% 33
2019
Q1 		$2.23M Buy
+41,320
New +$2.55M 1.1% 30
2018
Q2 		– Sell
-30,615
Closed -$1.91M – 79
2018
Q1 		$1.91M Buy
30,615
+9,800
+47% +$703K 0.88% 35
2017
Q4 		$1.51M Sell
20,815
-3,670
-15% -$267K 0.7% 43
2017
Q3 		$1.99M Sell
24,485
-105
-0.4% -$8.31K 0.99% 30
2017
Q2 		$1.98M Buy
24,590
+5
+0% +$395 1.04% 30
2017
Q1 		$1.93M Buy
24,585
+3,925
+19% +$313K 1.1% 31
2016
Q4 		$1.63M Sell
20,660
-1,170
-5% -$94.7K 0.97% 35
2016
Q3 		$1.94M Buy
+21,830
New +$2.06M 1.12% 35

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Meridian Management's CVS Position: Q3 2023 in Review

Meridian Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 61,210 shares — an estimated $4.23M sold.

Meridian Management first reported a position in CVS in Q3 2016 and held it in 25 quarters. The position peaked at $5.82M in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Meridian Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Meridian Management sold 61,210 CVS Health shares in Q3 2023, an estimated $4.23M.
  • Meridian Management first reported a position in CVS Health in Q3 2016 and held it in 25 quarters.
  • Meridian Management's CVS Health position peaked at $5.82M in Q4 2021.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Meridian Management's 13F filing for Q3 2023, filed 3 Nov 2023.